Search research articles
Contact Us
Filters
Showing results (131-140 of 412) with videos related to
Page
of 42
Sort By:
Urologic Oncology
|
January 11, 2021
Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review
Ekaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 28, 2023
A Standardized Method for Estimating the Carbon Footprint of Disposable Minimally Invasive Surgical Devices: Application in Transurethral Prostate Surgery
Vincent Misrai, Enrique Rijo, Jean-Baptiste Cottenceau, et al.
World Journal of Urology
|
August 7, 2023
5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data
Francesco Del Giudice, Federico Belladelli, Frank Glover, et al.
European Urology Oncology
|
March 24, 2021
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
Fahad Quhal, Keiichiro Mori, Andreas Bruchbacher, et al.
Immunotherapy
|
July 6, 2023
Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis
Tatsushi Kawada, Takafumi Yanagisawa, Kensuke Bekku, et al.
Cancer Treatment Reviews
|
June 21, 2021
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis
Keiichiro Mori, Benjamin Pradere, Fahad Quhal, et al.
European Urology Focus
|
June 13, 2026
First-line Therapy for Metastatic Renal Cell Carcinoma: An Updated Network Meta-analysis using Final Follow-up Data
Takafumi Yanagisawa, Keiichiro Mori, Wataru Fukuokaya, et al.
Journal of Endourology
|
December 21, 2021
Predictive Factors of Early Postoperative Complications After Robot-Assisted Radical Cystectomy for Urothelial Bladder Carcinoma
Marie Mermier, Pierre Baron, Mathieu Roumiguié, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
April 29, 2025
Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates
Takafumi Yanagisawa, Akihiro Matsukawa, Jeremy Yuen-Chun Teoh, et al.
Minerva Urology and Nephrology
|
April 29, 2025
Radical cystectomy for bladder cancer in solid organ transplant recipients
Elena Tonin, Lorenzo Bianchi, Angelo Mottaran, et al.
Page
of 42
Search research articles
Search
Showing results (131-140 of 412) with videos related to
Sort By:
Page
of 42
Urologic Oncology
|
January 11, 2021
Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review
Ekaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 28, 2023
A Standardized Method for Estimating the Carbon Footprint of Disposable Minimally Invasive Surgical Devices: Application in Transurethral Prostate Surgery
Vincent Misrai, Enrique Rijo, Jean-Baptiste Cottenceau, et al.
World Journal of Urology
|
August 7, 2023
5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data
Francesco Del Giudice, Federico Belladelli, Frank Glover, et al.
European Urology Oncology
|
March 24, 2021
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
Fahad Quhal, Keiichiro Mori, Andreas Bruchbacher, et al.
Immunotherapy
|
July 6, 2023
Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis
Tatsushi Kawada, Takafumi Yanagisawa, Kensuke Bekku, et al.
Cancer Treatment Reviews
|
June 21, 2021
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis
Keiichiro Mori, Benjamin Pradere, Fahad Quhal, et al.
European Urology Focus
|
June 13, 2026
First-line Therapy for Metastatic Renal Cell Carcinoma: An Updated Network Meta-analysis using Final Follow-up Data
Takafumi Yanagisawa, Keiichiro Mori, Wataru Fukuokaya, et al.
Journal of Endourology
|
December 21, 2021
Predictive Factors of Early Postoperative Complications After Robot-Assisted Radical Cystectomy for Urothelial Bladder Carcinoma
Marie Mermier, Pierre Baron, Mathieu Roumiguié, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
April 29, 2025
Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates
Takafumi Yanagisawa, Akihiro Matsukawa, Jeremy Yuen-Chun Teoh, et al.
Minerva Urology and Nephrology
|
April 29, 2025
Radical cystectomy for bladder cancer in solid organ transplant recipients
Elena Tonin, Lorenzo Bianchi, Angelo Mottaran, et al.
Page
of 42